Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Molecular Biosystems
|
January 12, 2011
Precise measurement of protein interacting fractions with fluorescence lifetime imaging microscopy
Kirstin A Walther, Björn Papke, Maja B Sinn, et al.
Cell
|
April 15, 2014
KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport
Malte Schmick, Nachiket Vartak, Björn Papke, et al.
Nature
|
May 24, 2013
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann, Björn Papke, Shehab Ismail, et al.
Cell Death and Differentiation
|
April 9, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
Science Signaling
|
July 22, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer
Oleksandra Aust, Moritz R T Thiel, Eric Blanc, et al.
Nature Communications
|
April 21, 2016
Identification of pyrazolopyridazinones as PDEδ inhibitors
Björn Papke, Sandip Murarka, Holger A Vogel, et al.
Cancer Research
|
December 18, 2021
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors
Clint A Stalnecker, Kajal R Grover, A Cole Edwards, et al.
Journal of Translational Medicine
|
August 16, 2024
Viscoelastic properties of colorectal liver metastases reflect tumour cell viability
Lisa-Marie Skrip, Simon Moosburner, Peter Tang, et al.
The Journal of Biological Chemistry
|
October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Molecular Biosystems
|
January 12, 2011
Precise measurement of protein interacting fractions with fluorescence lifetime imaging microscopy
Kirstin A Walther, Björn Papke, Maja B Sinn, et al.
Cell
|
April 15, 2014
KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport
Malte Schmick, Nachiket Vartak, Björn Papke, et al.
Nature
|
May 24, 2013
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann, Björn Papke, Shehab Ismail, et al.
Cell Death and Differentiation
|
April 9, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, et al.
Science Signaling
|
July 22, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer
Oleksandra Aust, Moritz R T Thiel, Eric Blanc, et al.
Nature Communications
|
April 21, 2016
Identification of pyrazolopyridazinones as PDEδ inhibitors
Björn Papke, Sandip Murarka, Holger A Vogel, et al.
Cancer Research
|
December 18, 2021
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors
Clint A Stalnecker, Kajal R Grover, A Cole Edwards, et al.
Journal of Translational Medicine
|
August 16, 2024
Viscoelastic properties of colorectal liver metastases reflect tumour cell viability
Lisa-Marie Skrip, Simon Moosburner, Peter Tang, et al.
The Journal of Biological Chemistry
|
October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Page
of 2